Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys.
Recent efforts have been made to develop a chemical oviductal occluding agent. Intrauterine quinacrine has been used in certain areas of the world with moderate success in effected tubal closure. This report presents the pharmacokinetics of a quinacrine solution (30 mg) as administered to cynomolgus monkeys via the intrauterine route, compared with intravascular injection. The data show rapid transfer of the drug from the uterine to the vascular compartment and uptake by almost all tissues examined. Although plasma concentrations disappear within 24 hours, levels can be detected in most tissues for at least 1 week following intrauterine injection. After 28 days, however, tissue levels of the drug are absent or near the limit of detection.
D000818:Animals; D005260:Female; D007275:Injections, Intravenous; D007700:Kinetics; D008252:Macaca fascicularis; D011796:Quinacrine / Q000008:administration & dosage / Q000378:metabolism*; D014599:Uterus
D011796:Quinacrine